(Q38746808)

6 September 2017

1 reference

title

Estrogen replacement therapy: indications, contraindications, and agent selection (English)

1 reference

6 September 2017

1 reference

1 reference

1 reference

Notelovitz M

1

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

American Journal of Obstetrics and Gynecology

6 September 2017

published in

1 reference

6 September 2017

volume

161

1 reference

6 September 2017

issue

6 Pt 2

1 reference

6 September 2017

page(s)

1832-1841

1 reference

Estrogen replacement therapy: indications and complications

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Quantitative computed tomography for prediction of vertebral fracture risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Trabecular bone resorption depth decreases with age: differences between normal males and females.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Dietary risk factors for age-related bone loss and fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Risk factors for spinal osteoporosis in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Relative contributions of aging and estrogen deficiency to postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Long-term estrogen replacement therapy prevents bone loss and fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen use in postmenopausal women--costs, risks, and benefits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Prevention of spinal osteoporosis in oophorectomised women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Benefits and risks of menopausal estrogen and/or progestin hormone use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen replacement therapy: current recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Investigation of relation between use of oral contraceptives and thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Thromboembolism and oral contraceptives: an epidemiologic case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

A prospective study of postmenopausal estrogen therapy and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen use and cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Coronary risk and estrogen use in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Myocardial infarction and estrogen therapy in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen-induced regression of coronary atherosclerosis in cholesterol-fed chicks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Postmenopausal oestrogen treatment and stroke: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen replacement therapy and protection from acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Biological Effects of Various Doses of Vaginally Administered Conjugated Equine Estrogens in Postmenopausal Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Biologic effects of transdermal estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Assessment of the potency of orally administered progestins in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effects of different progestogens on lipoproteins during postmenopausal replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen use and blood pressure in later life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

The effect of type and dose of oestrogen on the blood pressure of post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

The menopause: benefits and risks of estrogen-progestogen replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Association of Exogenous Estrogen and Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Estrogens and Endometrial Cancer in a Retirement Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Exogenous estrogen and endometrial carcinoma: Case-control and incidence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Endometrial hyperplasia in women on cyclic or continuous estrogen regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Increased prostacyclin-like activity in vascular tissues from rats on long-term treatment with an oestrogen-progestagen combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Regulation of prostacyclin and thromboxane production by human umbilical vessels: the effect of estradiol and progesterone in a superfusion model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Conjugated equine oestrogens and blood clotting: a follow-up report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Letter: Natural oestrogen replacement therapy and blood clotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

The relationship of headache frequency to hormone use in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

The effect of estrogen dose on postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Comparison of pharmacodynamic properties of various estrogen formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

Post-menopausal osteoporosis. A practical approach to its prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. II. Plasma lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980003-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(89)80003-1

1 reference

6 September 2017

1 reference